Product logins

Find logins to all Clarivate products below.


Orthopedic Biomaterials | Europe | 2015 | Market Analysis

Despite recent and ongoing obstacles to growth, including considerable economic difficulties and a deteriorating reimbursement environment, the European orthopedic biomaterial market will show moderate expansion through 2023 as favorable demographics contribute to procedure volume growth that will offset downward pricing pressures.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic biomaterials in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Hyaluronic Acid Viscosupplementation – Market Insights – Global
The global HA viscosupplementation market will grow modestly over the forecast period. This growth will be supported by an aging population and a rising number of people with OA. Better patient…
Report
Bone Graft Substitutes – Market Insights – Global
Long-term growth in the global BGS market will be driven by the uptake of novel technologies, the expanding indication approvals, site-of-service flexibility, and strategic mergers and acquisitions…
Report
Large-Joint Reconstructive Implants – Market Insights – United States
The large-joint reconstructive implant market is driven by an expanding older population and a more active younger population in the US. The shift of procedures to the ASC and outpatient settings…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…